FDANonrulemakingFDA-2016-D-4318

Who commented on this docket

Compounding and Repackaging of Radiopharmaceuticals By State-Licensed Nuclear Pharmacies and Federal Facilities; Draft Guidance for Industry; Availability

6 organizations filed 6 public comments on Compounding and Repackaging of Radiopharmaceuticals By State-Licensed Nuclear Pharmacies and Federal Facilities; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2904d ago.

Organizations
6
Comments
6
RIN
Comment window
closed 2904d ago

Commenters (6)

  • Council on Radionuclides and Radiopharmaceuticals CORARtrade assoc.
    1 filing · confidence 85%
  • GE Healthcare Incunverified attribution
    1 filing · confidence 70%
  • National Association of Nuclear Pharmaciestrade assoc.
    1 filing · confidence 85%
  • Society of Nuclear Medicine and Molecular Imagingtrade assoc.
    1 filing · confidence 85%
  • UPPI LLCunverified attribution
    1 filing · confidence 70%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.